Gateway's sale of Healthway Medical notes to third parties raises eyebrows
Singapore
AHEAD of Healthway Medical Corporation's (HMC) extraordinary general meeting (EGM) to vote on the second tranche of S$60 million convertible notes, some minority shareholders have raised concerns whether private-equity fund Gateway Partners is there to make a quick buck at their expense.
Questions have risen over why Gateway chose to sell its first tranche of S$10 million in convertible notes to third parties after Lippo-linked Gentle Care has made an offer to buy over these notes at the same price it is offering to pay for each share of HMC.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Hot stock: Singtel down about 3.3% after announcing S$3.1 billion impairment hit
Perpetual in talks with KKR for corporate trust and wealth management unit sale
SK Innovation expects solid Q2 refining margins, battery unit widen losses
BYD shares face earnings test as China’s EV price war heats up
Singapore stocks decline at Monday’s open; STI down 0.3%
RBNZ says insurance may become unaffordable for high-risk homes